Dow Surges 400 Points; Crude Oil Down 1%
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 400 points on Monday.
Looking Into Verve Therapeutics’s Recent Short Interest
Verve Therapeutics's (NASDAQ:VERV) short percent of float has fallen 11.53% since its last report. The company recently reported that it has 10.73 million shares sold short, which is 33.6% of all regular shares that are available for trading.
Dow Jumps Over 200 Points; Verve Therapeutics Shares Plummet
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 200 points on Monday.
Verve Therapeutics Shares Tumble After FDA Hold On Trial For Elevated Cholesterol Level Candidate
The FDA has instituted a clinical hold on Verve Therapeutics Inc’s (NASDAQ:VERV) IND application to conduct a clinical trial evaluating VERVE-101 in…
TreeHouse Foods, Ritchie Bros. Auctioneers, Beam Therapeutics And Some Other Big Stocks Moving Lower On Monday
U.S. stocks traded mostly higher, with the Dow Jones gaining more than 150 points on Monday. Here are some big stocks recording losses in today’s session.
US Stocks Mixed; Dow Rises Over 50 Points
U.S. stocks traded mixed this morning, with the Dow Jones gaining over 50 points on Monday.
12 Health Care Stocks Moving In Monday’s Pre-Market Session
Gainers
Cidara Therapeutics (NASDAQ:CDTX) shares rose 14.6% to $0.64 during Monday's pre-market session. The market value of their outstanding shares is at $44.9 million. The company's, Q3 earnings came out 2 days ago.
Verve’s Stock Price Could Continue To Rise Through Clinical Progress – Despite Worries About “DeeperPocketed” Competition
Credit Suisse has initiated coverage on Verve Therapeutics Inc (NASDAQ:VERV) with a Neutral rating and a $48 target price. Its lead assets…
A Look Into Healthcare Sector Value Stocks
The Meaning Behind Value Stocks
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.